DIRECT BIOLOGICS LLC

In News

Austin Inno - Poppi cracks open a new funding round | Tesla rental company opens in Austin - The Business Journals

The Business Journals - Mar 14, 2026

Exosomes: Company Spotlights from "A" to "Z" - BioInformant

BioInformant - Feb 06, 2026

Biotech targeting chronic diseases raises $1.7M in stock sale - Stock Titan

Stock Titan - Dec 16, 2025

Rapid Micro Biosystems Receives Multi-System Order from Samsung Biologics to Expand Growth Direct Platform for Microbial Quality Control Automation - Quiver Quantitative

Quiver Quantitative - Mar 12, 2026

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

CGTLive® - Dec 04, 2023

Rapid Micro Biosystems Announces Follow-on Multi-System - GlobeNewswire

GlobeNewswire - Mar 12, 2026

Acute Respiratory Distress Syndrome Pipeline 2026: Therapies - openpr.com

openpr.com - Mar 19, 2026

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - newswire.com

newswire.com - Jan 12, 2021

Direct Biologics LLC announced that it expects to receive $100 million in funding from IB Investments 1 LLC, and other investors - marketscreener.com

marketscreener.com - Sep 26, 2022

Direct Biologics Appoints Dr. Amy Lightner as Chief Medical Officer - citybiz

citybiz - Feb 15, 2023

ADMA Biologics (ADMA) CEO exercises options and sells 21K shares - Stock Titan

Stock Titan - Mar 17, 2026

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment